Search

everythinglearnresearchcommunity

for

Search:↓

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Prediabetes may be a risk factor for hair loss.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.